Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis
被引:0
|
作者:
Gianfranco Lessiani
论文数: 0引用数: 0
h-index: 0
机构:“Villa Serena” Hospital,Department of Angiology
Gianfranco Lessiani
Angela Falco
论文数: 0引用数: 0
h-index: 0
机构:“Villa Serena” Hospital,Department of Angiology
Angela Falco
Elvira Nicolucci
论文数: 0引用数: 0
h-index: 0
机构:“Villa Serena” Hospital,Department of Angiology
Elvira Nicolucci
Giancarlo Rolandi
论文数: 0引用数: 0
h-index: 0
机构:“Villa Serena” Hospital,Department of Angiology
Giancarlo Rolandi
Giovanni Davì
论文数: 0引用数: 0
h-index: 0
机构:“Villa Serena” Hospital,Department of Angiology
Giovanni Davì
机构:
[1] “Villa Serena” Hospital,Department of Angiology
[2] “Villa Serena” Hospital,Department of Orthopedic Surgery
[3] “Villa Serena” Hospital,Department of Hematology
[4] Civil Hospital,undefined
[5] “G. d’Annunzio” University Foundation,undefined
来源:
Journal of Thrombosis and Thrombolysis
|
2009年
/
27卷
关键词:
Factor XII deficiency;
Deep venous thrombosis;
Myocardial infarction;
Thrombotic risk;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Factor XII deficiency is associated with increased risk for both arterial and venous thrombosis. We describe a case of DVT involving superficial femoral and popliteal vein occurred following total hip replacement and despite prophylaxis with low molecular weight heparin in a subject with previous acute myocardial infarction (AMI). Tests of haemostasis documented a slightly prolonged activated partial thromboplastin time (APTT) (45′′) due to mild factor XII deficiency (clotting activity 32%). A therapeutic dose of enoxaparin was started, together with warfarin therapy. The patient was advised to continue oral anticoagulation indefinitely. Although cases of both venous and arterial thrombosis in carriers of severe factor XII deficiency have been already reported, to our knowledge this is the first case in the literature occurred in a carrier of partial factor XII deficiency. In conclusion, factor XII deficiency should be suspected if a patient presents with recurrent arterial and/or venous thrombosis and prolonged APTT. If this defect is diagnosed, in the presence of a history of thrombotic events, lifelong anticoagulation could be considered.